Best for
All-rounder
How to buy Zimmer Biomet shares | $148.7714
Own Zimmer Biomet shares in just a few minutes. Share price changes are updated daily.
Fact checked
Zimmer Biomet Holdings, Inc (ZBH) is a leading medical devices business based in the US. It opened the day at $147.2 after a previous close of $148.85. During the day the price has varied from a low of $148.65 to a high of $148.87. The latest price was $148.7714 (25 minute delay). Zimmer Biomet is listed on the NYSE and employs 19,900 staff. All prices are listed in US Dollars.
How to buy shares in Zimmer Biomet
- Choose a platform. If you're a beginner, our share-dealing table below can help you choose.
- Open your account. You'll need your ID, bank details and national insurance number.
- Confirm your payment details. You'll need to fund your account with a bank transfer, debit card or credit card.
- Search the platform for stock code: ZBH in this case.
- Research Zimmer Biomet shares. The platform should provide the latest information available.
- Buy your Zimmer Biomet shares. It's that simple.
Best for
Low-cost trading
Best for
US shares
Best for
Beginners
What's in this guide?
- Can I buy shares in Zimmer Biomet?
- Has coronavirus impacted Zimmer Biomet shares?
- Zimmer Biomet shares summary
- Compare share dealing platforms
- Is Zimmer Biomet stock a buy or sell?
- Zimmer Biomet performance over time
- Can I short Zimmer Biomet shares?
- Is Zimmer Biomet suitable for ethical investing?
- Are Zimmer Biomet shares over-valued?
- Zimmer Biomet's financials
- How volatile are Zimmer Biomet shares?
- Does Zimmer Biomet pay a dividend?
- Other common questions
How has Coronavirus impacted Zimmer Biomet's share price?
Since the stock market crash in March caused by coronavirus, Zimmer Biomet's share price has had significant negative movement.
Its last market close was $146.93, which is 6.65% down on its pre-crash value of $157.39 and 97.57% up on the lowest point reached during the March crash when the shares fell as low as $74.37.
If you had bought $1,000 worth of Zimmer Biomet shares at the start of February 2020, those shares would have been worth $543.85 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth $988.84.
Zimmer Biomet share price
Use our graph to track the performance of ZBH stocks over time.Zimmer Biomet shares at a glance
Information last updated 2020-12-17.
| Open | $147.2 |
|---|---|
| High | $148.87 |
| Low | $148.65 |
| Close | $148.7714 |
| Previous close | $148.85 |
| Change | $-0.079 |
| Change % | -0.053% |
| Volume | 9,501 |
Information last updated 2020-12-26.
| 52-week range | $73.7819 - $164.884 |
|---|---|
| 50-day moving average | $148.16 |
| 200-day moving average | $137.8897 |
| Wall St. target price | $161.31 |
| PE ratio | 814.8235 |
| Dividend yield | $0.96 (0.64%) |
| Earnings per share (TTM) | $0.178 |
Invest in Zimmer Biomet shares with 0% commission
Other fees may apply. Your capital is at risk.
- Unlimited trades, with no dealing charges or management fees
- If your trades get copied you can earn extra money
- Create an account today in a few minutes
Go to site
Capital at risk
Share dealing platform comparison
Table: sorted by promoted deals first
All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.
Is it a good time to buy Zimmer Biomet stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Zimmer Biomet price performance over time
Historical closes compared with the last close of $148.7714
| 3 months (2020-10-16) | 1.25% |
|---|---|
| 6 months (2020-07-17) | 10.09% |
Is Zimmer Biomet under- or over-valued?
Valuing Zimmer Biomet stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Zimmer Biomet's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Zimmer Biomet's P/E ratio
Zimmer Biomet's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 815x. In other words, Zimmer Biomet shares trade at around 815x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Zimmer Biomet's PEG ratio
Zimmer Biomet's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 38.5315. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Zimmer Biomet's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Zimmer Biomet's EBITDA
Zimmer Biomet's EBITDA (earnings before interest, taxes, depreciation and amortisation) is a whopping $1.9 billion (£1.4 billion).
The EBITDA is a measure of a Zimmer Biomet's overall financial performance and is widely used to measure a its profitability.
Zimmer Biomet financials
| Revenue TTM | $7.1 billion |
|---|---|
| Operating margin TTM | 12.91% |
| Gross profit TTM | $5.7 billion |
| Return on assets TTM | 2.36% |
| Return on equity TTM | -1.25% |
| Profit margin | -2.15% |
| Book value | $57.271 |
| Market capitalisation | $30.9 billion |
TTM: trailing 12 months
How to short and sell Zimmer Biomet shares
- Create a CFD or spread betting account.
- Search for the stock code. E.g. "ZBH.US"
- Choose your position size.
- Select "sell" rather than "buy".
- Confirm your position and keep tabs on it. You may wish to set limits on your position.
There are currently 2.2 million Zimmer Biomet shares held short by investors – that's known as Zimmer Biomet's "short interest". This figure is 8.2% up from 2.0 million last month.
There are a few different ways that this level of interest in shorting Zimmer Biomet shares can be evaluated.
Zimmer Biomet's "short interest ratio" (SIR)
Zimmer Biomet's "short interest ratio" (SIR) is the quantity of Zimmer Biomet shares currently shorted divided by the average quantity of Zimmer Biomet shares traded daily (recently around 1.0 million). Zimmer Biomet's SIR currently stands at 2.12. In other words for every 100,000 Zimmer Biomet shares traded daily on the market, roughly 2120 shares are currently held short.
However Zimmer Biomet's short interest can also be evaluated against the total number of Zimmer Biomet shares, or, against the total number of tradable Zimmer Biomet shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Zimmer Biomet's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 Zimmer Biomet shares in existence, roughly 10 shares are currently held short) or 0.0106% of the tradable shares (for every 100,000 tradable Zimmer Biomet shares, roughly 11 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Zimmer Biomet.
Find out more about how you can short Zimmer Biomet stock.
Zimmer Biomet's environmental, social and governance track record
Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like Zimmer Biomet.
When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.
Zimmer Biomet's total ESG risk score
Total ESG risk: 40.16
Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and Zimmer Biomet's overall score of 40.16 (as at 01/01/2019) is pretty weak – landing it in it in the 77th percentile of companies rated in the same sector.
ESG scores are increasingly used to estimate the level of risk a company like Zimmer Biomet is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).
Zimmer Biomet's environmental score
Environmental score: 9.29/100
Zimmer Biomet's environmental score of 9.29 puts it squarely in the 9th percentile of companies rated in the same sector. This could suggest that Zimmer Biomet is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.
Zimmer Biomet's social score
Social score: 23.4/100
Zimmer Biomet's social score of 23.4 puts it squarely in the 9th percentile of companies rated in the same sector. This could suggest that Zimmer Biomet is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.
Zimmer Biomet's governance score
Governance score: 16.46/100
Zimmer Biomet's governance score puts it squarely in the 9th percentile of companies rated in the same sector. That could suggest that Zimmer Biomet is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.
Zimmer Biomet's controversy score
Controversy score: 2/5
ESG scores also evaluate any incidences of controversy that a company has been involved in. A high-profile company, Zimmer Biomet scored a 2 out of 5 for controversy – the second-highest score possible, reflecting that Zimmer Biomet has, for the most part, managed to keep its nose clean.
Environmental, social, and governance (ESG) summary
Zimmer Biomet Holdings, Inc was last rated for ESG on: 2019-01-01.
| Total ESG score | 40.16 |
|---|---|
| Total ESG percentile | 77.24 |
| Environmental score | 9.29 |
| Environmental score percentile | 9 |
| Social score | 23.4 |
| Social score percentile | 9 |
| Governance score | 16.46 |
| Governance score percentile | 9 |
| Level of controversy | 2 |
Zimmer Biomet share dividends
Dividend payout ratio: 16.38% of net profits
Recently Zimmer Biomet has paid out, on average, around 16.38% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0.64% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Zimmer Biomet shareholders could enjoy a 0.64% return on their shares, in the form of dividend payments. In Zimmer Biomet's case, that would currently equate to about $0.96 per share.
While Zimmer Biomet's payout ratio might seem low, this can signify that Zimmer Biomet is investing more in its future growth.
Zimmer Biomet's most recent dividend payout was on 29 January 2021. The latest dividend was paid out to all shareholders who bought their shares by 24 December 2020 (the "ex-dividend date").
Zimmer Biomet share price volatility
Over the last 12 months, Zimmer Biomet's shares have ranged in value from as little as $73.7819 up to $164.884. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Zimmer Biomet's is 1.3297. This would suggest that Zimmer Biomet's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Win £500 to get your trading started
Subscribe to trending stock alerts for a chance to win
Zimmer Biomet overview
Zimmer Biomet Holdings, Inc., together with its subsidiaries, designs, manufactures, and markets musculoskeletal healthcare products and solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in four segments: Spine, less Asia Pacific; Office Based Technologies; Craniomaxillofacial and Thoracic; and Dental. The company provides orthopaedic reconstructive products, such as knee and hip replacement products; S.E.T. products, including surgical, sports medicine, biologics, foot and ankle, extremities, and trauma products; spine products comprising medical devices and surgical instruments; and face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest. It also offers dental products that include dental reconstructive implants, and dental prosthetic and regenerative products; and bone cement and office based technology products. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, oral surgeons, dentists, hospitals, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.
Frequently asked questions
More guides on Finder
-
How to buy Lemonade shares | $50.05
Learn more about Lemonade’s recent performance and where you can invest in Lemonade shares. We also run through some helpful rules of thumb for any investor.
-
How to buy Unity Software shares | $111.51
Learn more about Unity Software’s recent performance and where you can invest in Unity Software shares. We also run through some helpful rules of thumb for any investor
-
How to buy FuelCell Energy shares | $3.745
Learn more about FuelCell Energy’s recent performance and where you can invest in FuelCell Energy shares. We also run through some helpful rules of thumb for any investor.
-
How to buy CloudCommerce shares | $0.1275
Learn more about CloudCommerce’s recent performance and where you can invest in CloudCommerce shares. We also run through some helpful rules of thumb for any investor
-
How to buy Zomedica Pharmaceuticals shares | $0.93
Ever wondered how to buy shares in Zomedica Pharmaceuticals? We explain how and compare a range of providers that can give you access to many brands, including Zomedica Pharmaceuticals.
-
How to buy YRC Worldwide shares | $4.66
Ever wondered how to buy shares in YRC Worldwide? We explain how and compare a range of providers that can give you access to many brands, including YRC Worldwide.
-
How to buy Xeros Technology Group shares | 220p
Ever wondered how to buy shares in Xeros Technology Group? We explain how and compare a range of providers that can give you access to many brands, including Xeros Technology Group.
-
How to buy Xpediator shares | 33.5p
Ever wondered how to buy shares in Xpediator? We explain how and compare a range of providers that can give you access to many brands, including Xpediator.
-
How to buy Van Elle Holdings shares | 42p
Ever wondered how to buy shares in Van Elle Holdings? We explain how and compare a range of providers that can give you access to many brands, including Van Elle Holdings.
-
How to buy ULS Technology shares | 80.7p
Ever wondered how to buy shares in ULS Technology? We explain how and compare a range of providers that can give you access to many brands, including ULS Technology.
Ask an Expert